Found: 10
Select item for more details and to access through your institution.
Predicting survival in advanced hematologic malignancies: do patient-reported symptoms matter?
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 5, p. 410, doi. 10.1111/ejh.12004
- By:
- Publication type:
- Article
EDTA and temperature dependent neutrophil aggregation.
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 5, p. 435, doi. 10.1111/j.1600-0609.2012.01820.x
- By:
- Publication type:
- Article
Red cell and platelet-derived microparticles are increased in G6 PD-deficient subjects.
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 5, p. 423, doi. 10.1111/ejh.12010
- By:
- Publication type:
- Article
Acute myeloid leukemia with 11q23/ MLL rearrangement after ' FCR' regimen for chronic lymphocytic leukemia.
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 5, p. 430, doi. 10.1111/ejh.12001
- By:
- Publication type:
- Article
The relation of vascular endothelial growth factor ( VEGF) gene polymorphisms on VEGF levels and the risk of vasoocclusive crisis in sickle cell disease.
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 5, p. 403, doi. 10.1111/ejh.12003
- By:
- Publication type:
- Article
Hypoalbuminaemia is an independent predictor for hemophagocytic lymphohistiocytosis in childhood Epstein- Barr virus-associated infectious mononucleosis.
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 5, p. 417, doi. 10.1111/ejh.12006
- By:
- Publication type:
- Article
A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma.
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 5, p. 385, doi. 10.1111/j.1600-0609.2012.01837.x
- By:
- Publication type:
- Article
Outcomes of patients with multiple myeloma and renal impairment treated with bortezomib, cyclophosphamide, and dexamethasone without plasma exchange.
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 5, p. 432, doi. 10.1111/ejh.12008
- By:
- Publication type:
- Article
High serum vascular endothelial growth factor level is an adverse prognostic factor for high-risk diffuse large B-cell lymphoma patients treated with dose-dense chemoimmunotherapy.
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 5, p. 395, doi. 10.1111/ejh.12005
- By:
- Publication type:
- Article
Targeting the vascular endothelial growth factor in hematologic malignancies.
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 5, p. 373, doi. 10.1111/ejh.12009
- By:
- Publication type:
- Article